Marketing-authorisation holder · Brazil
Produtos Roche Químicos E Farmacêuticos S.A.
107 medicines in 1 country, as authorisation holder and manufacturer.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 107
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Actemra | Tocilizumab | Brazil | Authorised | 2009 |
| ALECENSA | Alectinib | Brazil | Authorised | 2018 |
| AVASTIN | Bevacizumab | Brazil | Authorised | 2005 |
| CELLCEPT | Mycophenolate mofetil | Brazil | Authorised | 1996 |
| COLUMVI | Glofitamab | Brazil | Authorised | 2026 |
| COTELLIC | Cobimetinib | Brazil | Authorised | 2016 |
| Enspryng | Satralizumab | Brazil | Authorised | 2020 |
| ERIVEDGE | Vismodegib | Brazil | Authorised | 2016 |
| EVRYSDI | Risdiplam | Brazil | Authorised | 2020 |
| FUZEON | Enfuvirtide | Brazil | Authorised | 2004 |
| GAZYVA | Obinutuzumab | Brazil | Authorised | 2015 |
| Hemcibra | Emicizumab | Brazil | Authorised | 2018 |
| HERCEPTIN | Trastuzumab | Brazil | Authorised | 1999 |
| ITOVEBI | Inavolisib | Brazil | Authorised | 2026 |
| KADCYLA | Trastuzumabe entansina | Brazil | Authorised | 2014 |
| LUNSUMIO SC | Mosunetuzumab | Brazil | Authorised | 2026 |
| MABTHERA | Rituximab | Brazil | Authorised | 1998 |
| OCREVUS | Ocrelizumab | Brazil | Authorised | 2018 |
| Perjeta | Pertuzumab | Brazil | Authorised | 2013 |
| PHESGO | Pertuzumab, Trastuzumab | Brazil | Authorised | 2021 |
| Piasky | Crovalimab | Brazil | Authorised | 2025 |
| PROLOPA | Benserazide, Levodopa | Brazil | Authorised | 2001 |
| PULMOZYME | Alfadornase | Brazil | Authorised | 1995 |
| ROCEFIN | Ceftriaxona hemieptaidratada, Lidocaine | Brazil | Authorised | 1996 |
| ROPOLIVY | Polatuzumab vedotin | Brazil | Authorised | 2023 |